Blue light-activated 5,10,15,20-tetrakis(4-bromophenyl)porphyrin for photodynamic eradication of drug-resistant Staphylococcus aureus†
Hongshuang Qin, Huaying Niu, Yanxiang Guo, Xiaoting Wang, Tao Liu, Chuanqi Zhao · 2024
Read Blue light-activated 5,10,15,20-tetrakis(4-bromophenyl)porphyrin for photodynamic eradication of drug-resistant Staphylococcus aureus† by Hongshuang Qin, Huaying Niu, Yanxiang Guo, Xiaoting Wang, Tao Liu, Chuanqi Zhao (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11653106.txt.
Description
Hongshuang Qin and co-authors test a light-activated porphyrin against drug-resistant staph bacteria. Their twenty twenty-four paper uses blue light therapy, which suits skin infections since blue light stays shallow. Reactive oxygen made on the spot kills germs that shrug off antibiotics.
Five porphyrin variants were compared as light drugs for this role. The bromo form in the title led the set. Such light drugs are few for blue light, so each new candidate counts. The team read how well the compound wakes under blue light and wipes out resistant Staphylococcus aureus. Light therapy with a strong local drug could treat skin infections while sparing deep tissue.
Catalog record
| CREATOR | Hongshuang Qin, Huaying Niu, Yanxiang Guo, Xiaoting Wang, Tao Liu, Chuanqi Zhao |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |